This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kaohsiung Medical University. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Innovations by Ku-Chung Chen
Introduction
Ku-Chung Chen is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the fields of ophthalmology and cardiovascular health through his innovative patents. With a total of 2 patents, his work focuses on advanced methods for treating and diagnosing critical health conditions.
Latest Patents
One of his latest patents is a method for treating and/or preventing myopia. This method involves administering RNA interference (RNAi) to a subject, which counteracts another RNA interference that inhibits the expression of the PAX-6 gene. Specifically, this RNA interference includes microRNA-328. Another significant patent is a method of therapy and diagnosis of atherosclerosis. This method utilizes microRNA let-7g to inhibit the expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and block the pathogenesis of atherosclerosis. Additionally, it includes a diagnostic method that determines the levels of microRNA let-7g in serum or plasma samples.
Career Highlights
Ku-Chung Chen has worked at Kaohsiung Medical University, where he has contributed to research and development in medical science. His work has been instrumental in advancing therapeutic methods that address prevalent health issues.
Collaborations
Some of his notable coworkers include Suh-Hang Hank Juo and Ching-Yu Hu, who have collaborated with him on various research projects.
Conclusion
Ku-Chung Chen's innovative patents and contributions to medical science highlight his role as a significant inventor in Taiwan. His work continues to impact the fields of myopia treatment and atherosclerosis diagnosis.